{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190724",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "59441",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210134s000lbl.pdf",
              "date": "20190724",
              "type": "Label"
            },
            {
              "id": "59443",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/210134Orig1s000ltr.pdf",
              "date": "20190725",
              "type": "Letter"
            },
            {
              "id": "61041",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210134Orig1s000TOC.html",
              "date": "20191125",
              "type": "Review"
            },
            {
              "id": "63060",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/477_210134 glucagon clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "63061",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/478_210134 glucagon CDTL prea_0.pdf",
              "date": "19000101",
              "type": "Pediatric CDTL Review"
            },
            {
              "id": "63062",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/480_210134 glucagon clinpharm prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "63063",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/479_210134 glucagon statistical prea_0.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20250317",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "81629",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/210134s004lbl.pdf",
              "date": "20250318",
              "type": "Label"
            },
            {
              "id": "81633",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/210134Orig1s004ltr.pdf",
              "date": "20250318",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20201027",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65066",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210134s002lbl.pdf",
              "date": "20201029",
              "type": "Label"
            },
            {
              "id": "65120",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/210134Orig1s002ltr.pdf",
              "date": "20201102",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA210134",
      "sponsor_name": "AMPHASTAR PHARMS INC",
      "openfda": {
        "application_number": [
          "NDA210134"
        ],
        "brand_name": [
          "BAQSIMI"
        ],
        "generic_name": [
          "GLUCAGON"
        ],
        "manufacturer_name": [
          "Amphastar Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "0548-8351",
          "0548-8352"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "NASAL"
        ],
        "substance_name": [
          "GLUCAGON"
        ],
        "rxcui": [
          "2180666",
          "2180671"
        ],
        "spl_id": [
          "8d3aa4dd-737c-49b4-af0d-fe95e3bee54d"
        ],
        "spl_set_id": [
          "f1f5df9b-872f-44e5-a18f-f0b68e7e9254"
        ],
        "package_ndc": [
          "0548-8351-01",
          "0548-8352-02"
        ],
        "nui": [
          "N0000190852",
          "N0000190853",
          "N0000009340",
          "N0000009345",
          "N0000008636",
          "N0000008635",
          "N0000008652"
        ],
        "pharm_class_epc": [
          "Antihypoglycemic Agent [EPC]",
          "Gastrointestinal Motility Inhibitor [EPC]"
        ],
        "pharm_class_pe": [
          "Increased Gluconeogenesis [PE]",
          "Increased Glycogenolysis [PE]",
          "Decreased GI Smooth Muscle Tone [PE]",
          "Decreased GI Motility [PE]",
          "Decreased Glycolysis [PE]"
        ],
        "unii": [
          "76LA80IG2G"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "BAQSIMI",
          "active_ingredients": [
            {
              "name": "GLUCAGON",
              "strength": "3MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "NASAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}